Enoxaparin versus unfractionated heparin with fibrinolysis for ST-elevation myocardial infarction

Creative Commons License

Antman E., Morrow D., McCabe C., Murphy S., Ruda M., Sadowski Z., ...More

NEW ENGLAND JOURNAL OF MEDICINE, vol.354, no.14, pp.1477-1488, 2006 (SCI-Expanded) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 354 Issue: 14
  • Publication Date: 2006
  • Doi Number: 10.1056/nejmoa060898
  • Journal Name: NEW ENGLAND JOURNAL OF MEDICINE
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.1477-1488
  • Dokuz Eylül University Affiliated: No

Abstract

Background: Unfractionated heparin is often used as adjunctive therapy with fibrinolysis in patients with ST-elevation myocardial infarction. We compared a low-molecular-weight heparin, enoxaparin, with unfractionated heparin for this purpose.